In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor

Journal of Clinical Investigation

Volumn 98, Issue 11, 1996, Pages 2507-2511

  Cao, Yihai ^a   Linden, Philip ^b   Shima, David ^b   Browne, Fiona ^b   Folkman, Judah ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

angiogenesis; placental growth factor; vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; CELL PROLIFERATION; CORNEA CELL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; NEOVASCULARIZATION (PATHOLOGY); PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TISSUE REGENERATION; TUMOR GROWTH;

EID: 0029849637     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119069     Document Type: Article

References (31)

1. Folkman, J., and Y. Shing. 1992. Angiogenesis. J. Biol. Chem. 267:10931-10934.
2. Folkman, J. 1995. Angiogenesis in cancer, vascular rheumatoid and other disease. Nat. Med. 1:27-31.
3. Folkman, J. 1995. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333:1757-1763.
4. Ferrara, N., and W.J. Henzel. 1989. Pituitary follicular cells secrete a novel heparin binding growth factor specific for Vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:851-858.
5. Gospodarowicz, D., J.A. Abraham, and J. Schilling. 1989. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. USA. 86:7311-7315.
6. Leung, D.W., G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Wash. DC). 246:1306-1309.
7. Senger, D.R., S.J. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash. DC). 219:983-985.
8. Ferrara, N., K. Houck, L. Jakeman, J. Winer, and D.W. Leung. 1991. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47: 211-218.
9. Ferrara, N., K. Houck, L. Jakeman, and D.W. Leung. 1992. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:18-32.
10. Shweiki, D., A. Itin, D. Soffer, and E. Keshet. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.). 359:843-845.
11. Shima, D.T., A.P. Adamis, N. Ferrara, K.-T. Yeo, P. Allende, J. Folkman, and P.A. D'Amore. 1995. Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol. Med. 1:182-193.
12. Mustonen, T., and K, Alitalo. 1995. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol. 129:895-898.
13. Thomas, K. 1996. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271:603-606.
14. Shibuya, M. 1995. Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv. Cancer Res. 67:281-316.
15. Carmeliet, P., V. Ferrara, G. Breier, S. Pollefeyt, L. Kiechens, M. Gertsenstein, M. Fahrig, A. Vandenhoek, K. Harpal, C. Eberhardt et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (Lond). 380:435-439.
16. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxtori, K.J. Hillan, and M.W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (Lond.). 380:439-442.
17. Fong, G.-H., J. Rossant, M. Gertsenstein, and M.L. Breitman. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (Lond). 376:66-70.
18. Shalaby, F., J. Rossant, T.P. Yamaguchi, M. Gertsenstein, X.-F. Wu, M.L. Breitman, and A.C. Schuh. 1995. Failure of blood-island formation and vasculogenesis in FIk-1-deficient mice. Nature (Lond.). 376:62-66.
19. Sato, T.N., Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau, and Y. Qin. 1995. Distinct roles of receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature (Lond.). 376:70-74.
20. Maglione, D., V. Guerriero, G. Viglietto, P. Delli-Bovi, and M.G. Persico. 1991. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA. 88:9267-9271.
21. Olofsson, B., K. Pajusola, A. Kaipainen, G. von Euler, V. Joukov, O. Saksela, A. Orpana, R.F. Pettersson, K. Alitalo, and U. Eriksson. 1996. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. USA. 93:2576-2581.
22. Joukov, V., K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Saksela, N. Kalkkinen, and K. Alitalo. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 and KDR (VEGFR-2) receptor tyrosine kinases. EMBO (Eur. Mol. Biol. Organ.) J. 15:290-298.
23. Maglione, D., V. Guerriero, G. Viglietto, M.G. Ferraro, O. Aprelikova, K. Alitalo, S.D. Vecchio, K.-J. Lei, J.Y. Chou, and M.G. Persico. 1993. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene. 8: 925-931.
24. Cao, Y., H. Chen, L. Zhou, M.-K. Chiang, B. Anand-Apte, J.A. Weatherbee, Y. Wang, F. Fang, J.G. Flanagan, and M.L.-S. Tsang. 1996. Heterodimers of placenta growth factor/vascular endothelial growth factor: endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J. Biol. Chem. 271:3154-3162.
25. DiSalvo, J., M.L. Bayne, G. Conn, P.W. Kwok, P.O. Trivedi, D.D. Soderman, T.M. Palisi, K.A. Sullivan, and K.A. Thomas. 1995. Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer. J. Biol. Chem. 270:7717-7723.
26. Park, J.E., H.E. Chen, J. Winer, and N. Ferrara. 1994. Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity in vitro and in vivo and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269:25646-25654.
27. Cao, Y., C. Chen, J.A. Weatherbee, M. Tsang, and J. Folkman. 1995. gro-β, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J. Exp. Med. 182:2067-2077.
28. Sawano, A., T. Takahashi, S. Yamaguchi, M. Aonuma, and M. Shibuya. 1996. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213-221.
29. Waltenberger, J., L. Claesson-Welsh, A. Siegbahn, M. Shibuya, and C.H. Heldin. 1994. Different signal transducting properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269:26988-26995.
30. Shima, D.T., U. Deutch, and P.A. D'Amore. 1995. Hypoxia induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS lett. 370:203-208.
31. Kenyon, B.M., E.E. Voest, C. Chen, E. Flynn, J. Folkman, and R.J. D'Amato. 1996. A model of angiogenesis in the mouse cornea. Invest. Ophthal. Visual Sci. 37:1625-1632.